Societal CDMO Inc (DELISTED) (SCTL:DL)
1.10
0.00 (0.00%)
USD |
NASDAQ |
Apr 08, 16:00
Societal CDMO Enterprise Value: 145.26M for April 8, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
April 08, 2024 | 145.26M |
April 05, 2024 | 145.26M |
April 04, 2024 | 144.20M |
April 03, 2024 | 144.20M |
April 02, 2024 | 144.20M |
April 01, 2024 | 145.26M |
March 28, 2024 | 143.15M |
March 27, 2024 | 144.20M |
March 26, 2024 | 144.20M |
March 25, 2024 | 143.15M |
March 22, 2024 | 144.20M |
March 21, 2024 | 141.03M |
March 20, 2024 | 143.15M |
March 19, 2024 | 144.20M |
March 18, 2024 | 144.20M |
March 15, 2024 | 144.20M |
March 14, 2024 | 144.07M |
March 13, 2024 | 144.07M |
March 12, 2024 | 144.07M |
March 11, 2024 | 141.96M |
March 08, 2024 | 143.02M |
March 07, 2024 | 140.91M |
March 06, 2024 | 141.96M |
March 05, 2024 | 140.91M |
March 04, 2024 | 140.91M |
Date | Value |
---|---|
March 01, 2024 | 141.96M |
February 29, 2024 | 141.96M |
February 28, 2024 | 77.56M |
February 27, 2024 | 84.11M |
February 26, 2024 | 86.00M |
February 23, 2024 | 82.16M |
February 22, 2024 | 81.43M |
February 21, 2024 | 81.99M |
February 20, 2024 | 80.38M |
February 16, 2024 | 81.29M |
February 15, 2024 | 81.74M |
February 14, 2024 | 80.86M |
February 13, 2024 | 78.49M |
February 12, 2024 | 80.38M |
February 09, 2024 | 81.42M |
February 08, 2024 | 77.24M |
February 07, 2024 | 80.37M |
February 06, 2024 | 77.44M |
February 05, 2024 | 76.20M |
February 02, 2024 | 70.61M |
February 01, 2024 | 71.46M |
January 31, 2024 | 63.69M |
January 30, 2024 | 63.60M |
January 29, 2024 | 65.71M |
January 26, 2024 | 65.68M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
60.62M
Minimum
Nov 15 2023
528.99M
Maximum
Feb 13 2020
184.73M
Average
159.01M
Median
Aug 24 2020
Enterprise Value Benchmarks
XOMA Corp | 282.73M |
Ironwood Pharmaceuticals Inc | 1.607B |
CymaBay Therapeutics Inc (DELISTED) | 3.443B |
Homology Medicines Inc (DELISTED) | -79.63M |
Amgen Inc | 223.14B |
Enterprise Value Related Metrics
Net Income (Quarterly) | -0.786M |
Revenue (Quarterly) | 27.72M |
Total Expenses (Quarterly) | 25.97M |
Gross Profit Margin (Quarterly) | 27.77% |
Profit Margin (Quarterly) | -2.84% |
Earnings Yield | -13.64% |
Normalized Earnings Yield | -13.64 |